US tech firm Nvidia buys stake in French health platform Doctolib - Yahoo News Canada
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Nvidia chief executive Jensen Huang announced the plans in Paris on Tuesday, saying they were intended to "launch the artificial intelligence revolution in Europe". Neither Nvidia nor the French companies disclosed the size or value of the stakes. Doctolib, one of France's best-known technology companies, said Nvidia would become a minority shareholder without a seat on its board. The platform, valued at €3.6 billion in its last funding round, allows patients to book medical appointments and store health records. Chief executive Stanislas Niox-Château said the investment would accelerate recruitment and the development of Doctolib's in-house artificial intelligence (AI) models. These are intended to power a personal health assistant for patients and assistants for medical staff, covering administrative and clinical tasks. EU steps up AI regulation as new transparency rules come into effectDoctolib will use Nvidia's chips, computing capacity and open software, while seeking to retain control of its models and patient data rather than relying on US AI providers such as OpenAI or Anthropic.
This article is an excerpt. To read the full content, visit the original source. Yahoo News Canada
Related articles
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
0 comments
No comments yet. Be the first to share your thoughts!